ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
ClearPoint Neuro Q1 Earnings Call Highlights
ClearPoint Neuro Reports First Quarter 2026 Results
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
Here Are Friday’s Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, Epam Systems, HubSpot, Nike, Shake Shack, Tapestry, Qualcomm, and More
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
ClearPoint Neuro: From Validation To Scale
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software
ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
Critical Survey: ClearPoint Neuro (NASDAQ:CLPT) vs. Sartorius (OTCMKTS:SARTF)
Investment strategist names 10 sub-$10 billion stocks to watch in 2026
ClearPoint Neuro Completes Acquisition of IRRAS
ClearPoint Neuro, Inc. (CLPT) Q3 2025 Earnings Call Transcript
ClearPoint Neuro: CRO Facility Should Reaccelerate Growth
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates
ClearPoint Neuro Reports Third Quarter 2025 Results
ClearPoint Neuro Announces Agreement to Acquire IRRAS
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint Neuro: AMT-130 Highlights A Bright Future
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
ClearPoint Neuro: Selling The Tools For Brain Therapies
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
ClearPoint Neuro: Biopharma Momentum Continues To Build
ClearPoint Neuro, Inc. (CLPT) Q2 2025 Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro Reports Second Quarter 2025 Results
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025
Move Over, Magnificent 7: The Frontier 7 Will Redefine Our Future
ClearPoint Neuro: Consumables Growth Is Promising